.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Harvard Business School
Teva
Chinese Patent Office
QuintilesIMS
Julphar
Mallinckrodt
McKesson
US Army
US Department of Justice

Generated: June 22, 2017

DrugPatentWatch Database Preview

IZBA Drug Profile

« Back to Dashboard

What is the patent landscape for Izba, and when can generic versions of Izba launch?

Izba is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-eight patent family members in twenty countries.

The generic ingredient in IZBA is travoprost. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the travoprost profile page.

Summary for Tradename: IZBA

Patents:4
Applicants:1
NDAs:1
Bulk Api Vendors: see list37
Patent Applications: see list1,334
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IZBA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo8,754,123► SubscribeY ► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo9,144,561► SubscribeY ► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo8,178,582► SubscribeY ► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo8,722,735► SubscribeY ► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: IZBA

Drugname Dosage Strength RLD Submissiondate
travoprostOphthalmic Solution0.003%Izba12/30/2015

International Patent Family for Tradename: IZBA

Country Document Number Estimated Expiration
HungaryE025619► Subscribe
Denmark2265251► Subscribe
European Patent Office2705836► Subscribe
Germany202009019087► Subscribe
Argentina070888► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: IZBA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
12/033Ireland► SubscribePRODUCT NAME: TRAVOPROST (ALSO CALLED FLUPROSTENOL ISOPROPYL ESTER); NAT REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; FIRST REGISTRATION NO/DATE: EU/1/01/199/001-002 20011129; PAEDIATRIC INVESTIGATION PLAN: P/0298/2013 PROCEEDINGS UNDER SECTION 37 OF THE PATENTS ACT, 1992 RESTORATION ORDER DATED 12TH JANUARY 2016, WAS MADE RESTORING THE PATENT MENTIONED BELOW S85583 PAUL DOYLE A RE-USABLE BAG SYSTEM RESTORATION ORDERS DATED 16TH FEBRUARY 2016, WERE MADE RESTORING THE PATENTS MENTIONED BELOW S86133 MERVYN GREENE MULTI PURPOSE TANK STAND WITH COMPLEX LOCKING MECHANISM 86119 MPC GREEN LIMITED ANEW BIN
2012017,C1920764Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
2014 00038Denmark► SubscribePRODUCT NAME: TRAVOPROST; REG. NO/DATE: EU/1/01/199/001-002 20011127
00671Netherlands► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EG EU/1/01/199/001-002 20011128
90027-0Sweden► SubscribePRODUCT NAME: TRAVOPROST
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Chubb
Accenture
Novartis
Boehringer Ingelheim
UBS
Moodys
Citi
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot